Literature DB >> 26522267

Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults.

Vera Ignjatovic1, Leonie Pelkmans2, Hilde Kelchtermans2, Raed Al Dieri2, Coen Hemker2, Romy Kremers2, Saartje Bloemen2, Vasiliki Karlaftis3, Chantal Attard4, Bas de Laat2, Paul Monagle5.   

Abstract

INTRODUCTION: Infants and children have a lower incidence of thrombosis compared with adults. Yet, the mechanism of blood clot formation and structure in infants and children, as the end product of coagulation, has not been studied. This study aimed to establish differences in the mechanism of thrombin generation, fibrin clot formation and response to thrombolysis in infants and children compared with adults.
MATERIALS AND METHODS: We studied thrombin generation, fibrin clot formation, structure and fibrinolysis in healthy infants, children and adults.
RESULTS: Younger populations had a decreased potential to generate thrombin, at a slower velocity compared with adults, correlating positively with age. Clot formation at venous shear rate was decreased in infants and children compared with adults, with increased time for fibrin formation, decreased fibrin formation velocity, resulting in decreased tendency for fibrin formation in younger populations. These differences were less pronounced at arterial shear rate. Studies of the fibrin clot structure in paediatric age groups showed a significantly larger pore size compared with adults, suggestive of a clot that is less resistant to fibrinolysis. The presence of tissue plasminogen activator (tPA) resulted in a significant decrease in the pore size of infants and children, but not in adults.
CONCLUSIONS: This is the first study to suggest that the mechanism of blood clot formation and nanostructure, as well as response to thrombolytic therapy is different in infants and children compared with adults.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Child; Fibrin; Scanning electron microscopy; Thrombin; Tissue plasminogen activator

Mesh:

Substances:

Year:  2015        PMID: 26522267     DOI: 10.1016/j.thromres.2015.10.034

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model.

Authors:  Conor McCafferty; Leo Lee; Tengyi Cai; Slavica Praporski; Julian Stolper; Vasiliki Karlaftis; Chantal Attard; David Myint; Leeanne M Carey; David W Howells; Geoffrey A Donnan; Stephen Davis; Henry Ma; Sheila Crewther; Vinh A Nguyen; Suelyn Van Den Helm; Natasha Letunica; Ella Swaney; David Elliott; Kanta Subbarao; Vera Ignjatovic; Paul Monagle
Journal:  EJHaem       Date:  2022-03-22

2.  Proteomic analysis identified potential age-associated prognostic biomarkers in pneumonia-derived paediatric sepsis.

Authors:  Ting Luo; Haipeng Yan; Xun Li; Youcai Deng; Jiaotian Huang; Liping Li; Zhenghui Xiao; Xiulan Lu
Journal:  Proteomics Clin Appl       Date:  2021-12-04       Impact factor: 3.603

3.  Predictors of circuit health in neonatal patients receiving extracorporeal membrane oxygenation (ECMO).

Authors:  Rita G Hazboun; Nada Darwish; Gianna Rotyliano-Sykes; Nayef Chahin; Jie Xu; John Miller; Christos Calaritis; Leroy Thacker; Russell Moores; Karen D Hendricks-Muñoz
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

4.  Coronavirus Disease (COVID-19) in Children: Indian Perspectives.

Authors:  Subramanian Senthilkumaran; Ramachandran Meenakshisundaram; Sweni Shah; Ponniah Thirumalaikolundusubramanian
Journal:  Indian Pediatr       Date:  2020-04-26       Impact factor: 1.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.